-
公开(公告)号:SK285989B6
公开(公告)日:2008-01-07
申请号:SK8772002
申请日:2002-06-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , NOSJEAN OLIVIER , BOULANGER MICHELLE , HUSSON-ROBERT BERNADETTE
IPC: C07D295/00 , A61K31/00 , C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185
Abstract: Described are compounds of the formula (I), in which the substituents have meaning described in claims, method for their preparation and pharmaceutical compositions containing thereof in the treatment of glucose intolerance and of disorders associated with hyperglycaemia, such as type II diabetes or obesity.
-
12.
公开(公告)号:CA2599658A1
公开(公告)日:2006-09-08
申请号:CA2599658
申请日:2006-02-28
Applicant: SERVIER LAB
Inventor: SANSILVESTRI-MOREL PATRICIA , RUPIN ALAIN , VERBEUREN TONY , WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , VALLEZ MARIE-ODILE
IPC: A61K31/352 , A61P7/02
-
公开(公告)号:AU2006219853A1
公开(公告)日:2006-09-08
申请号:AU2006219853
申请日:2006-02-28
Applicant: SERVIER LAB
Inventor: VERBEUREN TONY , BOUSSARD MARIE-FRANCOISE , VALLEZ MARIE-ODILE , SANSILVESTRI-MOREL PATRICIA , RUPIN ALAIN , WIERZBICKI MICHEL
IPC: A61K31/352 , A61P7/02
Abstract: Use of diosmetin compounds in obtaining pharmaceutical compositions intended for the prevention and/or treatment of thrombotic pathologies and pathologies with a risk of thrombosis.
-
公开(公告)号:NO322155B1
公开(公告)日:2006-08-21
申请号:NO20022891
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: BOULANGER MICHELLE , WIERZBICKI MICHEL , LEVENS NIGEL , NOSJEAN OLIVIER , HUSSON-ROBERT BERNADETTE , FOURQUEZ JEAN-MARIE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D237/14 , C07D277/04 , C07D277/22 , C07D295/185
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:DE60205538D1
公开(公告)日:2005-09-22
申请号:DE60205538
申请日:2002-06-12
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , ATASSI GHANEM , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , GUILBAUD NICOLAS , KRAUS-BERTHIER LAURENCE
IPC: C07D209/80 , A61K31/403 , A61K31/433 , A61K31/4439 , A61P35/00 , C07D209/94 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D491/04 , C07D491/056 , A61K31/407
Abstract: Indenoindolone derivatives (I), their isomers and salts with acids and bases are new. Indenoindolone derivatives (I), their isomers and salts with acids and bases are new; R = H, alkyl (optionally substituted by carboxy, alkoxycarbonyl, or NR10R11), or alkenyl; R1-R8 = H, alkyl (optionally substituted by aryl, carboxy or alkoxycarbonyl), OH, acyloxy, NR12R13, carboxy, alkoxy (optionally substituted by aryl or NR14R15), alkenyloxy, or to adjacent groups R1-R8 = 1 or 2C alkylenedioxy; R9 = H, aryl, heteroaryl or alkyl (optionally containing one or more unsaturations and optionally substituted by one or more aryl, heteroaryl, 3-8C cycloalkyl, CN, or NR17R18 groups); X = O or NR16; R10, R11, R14, R15, R17, R18 = alkyl; NR10+R11, NR14+R15, NR17+R18 = nitrogen heterocycle; R12, R13 = H, alkyl, or NR14R15; R16 = H, alkyl, aryl, or aryl alkyl. Where alkyl, alkoxy, acyloxy, alkenyl and alkenyloxy groups have up to 6 C atoms, aryl is defined as phenyl, biphenyl, or naphthyl (optionally substituted by one or more halogen, alkyl, alkenyl, alkoxy, phenoxy, nitro, CN, amino, mono- and di-alkylamino or 1-2C alkylenedioxy groups) and heteroaryl groups may be mono- or bicyclic of 5-12 members with 1-3 heteroatoms (O, N, S) and optionally substituted by halogen, alkyl, OH, alkoxy, polyhaloalkyl, amino, mono- and di-alkylamino groups, and nitrogen heterocycles are monocyclic having 5-7 members including 1-3 heteroatoms, one of which is N and the others may be O, N, or S. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:SI1270562T1
公开(公告)日:2004-12-31
申请号:SI200230031
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , C07D295/18 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:PT1270562E
公开(公告)日:2004-11-30
申请号:PT02291501
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOULANGER MICHELLE , LEVENS NIGEL , FOURQUEZ JEAN-MARIE , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER
IPC: A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , C07D295/18 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:EA004955B1
公开(公告)日:2004-10-28
申请号:EA200200574
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , A61K31/4025
Abstract: Соединениеформулы (I)вкоторойпредставляетсобойнеобязательнозамещенноенасыщенноеуглеводородноекольцо, имеющееот 4 до 8 атомовуглеродав кольце,Rи R, которыемогутбытьодинаковымиилиразличными, каждыйпредставляетсобойатомводородаилиацильнуюгруппу,Rи R, которыемогутбытьодинаковымиилиразличными, каждыйпредставляетсобойатомводородаилиалкильнуюгруппу,Rи R, которыемогутбытьодинаковымиилиразличными, каждыйпредставляетсобойатомводородаилиалкильнуюгруппу,или Rи Rсовместнос атомомазота, ихнесущим, образуютнеобязательнозамещенныйазотсодержащийгетероцикл,егостереоизомеры, атакжеегоаддитивныесолис фармацевтическиприемлемойкислотой.Лекарственныепрепараты.
-
公开(公告)号:ES2206438T3
公开(公告)日:2004-05-16
申请号:ES02290598
申请日:2002-03-11
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D487/06 , A61K31/407 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D487/04
Abstract: Compound of formula (I):wherein:R1, R2, R3, R4, R5, R6 and R8, which may be identical or different, each represents hydrogen, alkyl, arylalkyl, hydroxy, alkoxy, arylalkoxy, acyloxy, arylcarbonyloxy, carboxyalkyl or carboxy,R7 represents hydrogen, hydroxy, alkoxy, arylalkoxy, acyloxy or arylcarbonyloxy group,or one of R1 to R8, together with another of R1 to R8 adjacent to it, forms an alkylenedioxy,its optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
-
公开(公告)号:AR034861A1
公开(公告)日:2004-03-24
申请号:ARP020100952
申请日:2002-03-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D491/056 , A61K31/40 , A61K31/403 , A61K31/407 , A61K31/5377 , A61P3/04 , A61P3/10 , A61P5/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D209/80 , C07D209/94 , A61P25/00 , A61P25/08
Abstract: Un compuesto de indenoindolona de fórmula (1), en donde: R representa un átomo de hidrógeno o un grupo alquenilo C1-6 lineal o ramificado o alquilo C1-6 lineal o ramificado, opcionalmente sustituido por un grupo carboxi o por un grupo de fórmula -NRaRb en donde cada uno de Ra y Rb, que pueden ser iguales o diferentes, representan un átomo de hidrógeno o un grupo alquilo C1-6 lineal o ramificado, o forman junto con el átomo de nitrógeno que los lleva un heterociclo que contiene nitrógeno; cada uno de R1, R2, R3, R4, R5, R6, R7 y R8, que pueden ser iguales o diferentes, representan un átomo de hidrógeno o un grupo alquilo C1-6 lineal o ramificado, alquenilo C1-6 lineal o ramificado, hidroxi, alcoxi C1-6 lineal o ramificado, alqueniloxi C1-6 lineal o ramificado, arilo-alquilo C1-6 en donde la mitad alquilo es lineal o ramificada, arilo-alcoxi C1-6 en donde la mitad alcoxi es lineal o ramificada, carboxi, aciloxi C1-6 lineal o ramificado o arilcarboniloxi; o uno de los grupos R1 a R8 forma con uno adyacente de los grupos R1 a R8 un grupo alquilenodioxi C1-2, sus isómeros ópticos, cuando existen, y sales de adición de los mismos con un ácido o una base farmacéuticamente aceptable; con la condición de que: cuando R no representa un átomo de hidrógeno, entonces por lo menos uno de los grupos R1 a R8 representa un grupo hidroxi o alcoxi C1-6 lineal o ramificado; y los compuestos de fórmula (1) son distintos de indeno[1,2-b]indol-10(5H)-ona; entendiéndose que el término "arilo" significa fenilo, bifenililo, naftilo, o tetrahidronaftilo, siendo cada uno de estos grupos opcionalmente sustituido por uno o más átomos o grupos iguales o diferentes seleccionados entre átomos de halógeno y grupos alquilo C1-6 lineales o ramificados, grupos hidroxi, alcoxi C1-6 lineales o ramificados, polihaloalquilo C1-6 lineales o ramificados, grupos amino (opcionalmente sustituidos por uno o más grupos alquilo C1-6 lineales o ramificados), grupos nitro, acilo C1-6 lineales o ramificados y alquilenodioxi C1-2. También se divulga un procedimiento para la preparación del compuesto y una composición farmacéutica que lo comprende. El compuesto y la composición farmacéutica que lo comprende han probado ser útiles en el tratamiento de los trastornos del sistema melatoninérgico.
-
-
-
-
-
-
-
-
-